Prevention of Injury in Skilled Nursing Facilities Through Optimizing Medications
Launched by DUKE UNIVERSITY · Mar 8, 2024
Trial Information
Current as of July 09, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
After hospitalization for fracture, approximately 60% of older adults receive post-acute care in Skilled Nursing Facilities (SNFs), but fewer than 20% of these individuals receive medication optimization, which is evidence-based care known to prevent additional injurious falls, fractures, and mortality. Therefore, there is an opportunity to substantially improve care and patient outcomes in this setting. The purpose of this study is to determine the comparative efficacy of a Deprescribing Care Model designed to deprescribe fall related medications (FRIDs), a Bone Heath Service Model designe...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged 65 years or greater
- • Admitted to an enrolled SNF after hospitalized fracture
- • Completion of a medication optimization plan
- Exclusion Criteria:
- • Non-osteoporotic fracture (e.g. facial, digital, skull, at site of tumor or infection)
- • Eligible for Hospice or palliative care
- • Patient discharged or died prior to completion of a medication optimization plan
About Duke University
Duke University, a leading academic and research institution located in Durham, North Carolina, is renowned for its commitment to advancing healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, Duke conducts a wide array of clinical trials aimed at developing cutting-edge therapies and improving patient outcomes across various medical fields. The university's Clinical Research Institute provides comprehensive support for trial design, implementation, and regulatory compliance, ensuring that all research adheres to the highest ethical and scientific standards. Duke’s dedication to translating research findings into effective clinical practices underscores its role as a pivotal contributor to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Durham, North Carolina, United States
Boston, Massachusetts, United States
Patients applied
Trial Officials
Cathleen S Colon-Emeric, MD, MHS
Principal Investigator
Duke University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported